Latest Advances

  • Condition: Rapidly Progressive Interstitial Lung Disease in Pregnant Patient with Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis
  • Journal: Frontiers in immunology
  • Treatment Used: Combined Immunosuppressant Regimen
  • Number of Patients: 1
  • Published —
This case report describes a pregnant woman with clinically amyopathic dermatomyositis with positive anti-melanoma differentiation-associated gene 5 antibody treated with combined immunosuppressive therapy.
  • Condition: Juvenile Myositis
  • Journal: Current rheumatology reports
  • Treatment Used: Rescue Therapy with Intravenous I mmunoglobulin (IVIG) or Cyclophosphamide
  • Number of Patients: 0
  • Published —
This study presented evidence for the use of intravenous immunoglobulin (IVIG) and cyclophosphamide for juvenile patients with inflammatory myopathies (muscle weakness and rash).
  • Condition: Severe Refractory Dermatomyositis
  • Journal: Medicine
  • Treatment Used: Begelomad
  • Number of Patients: 1
  • Published —
This study presents a case of a 55 year old man with severe refractory dermatomyositis (DM) who was treated with begelomad.
  • Condition: Ulcerative Colitis with Dermatomyositis
  • Journal: World journal of gastroenterology
  • Treatment Used: Infliximab
  • Number of Patients: 1
  • Published —
In this study, researchers evaluated the outcomes of using infliximab to treat a patient who had ulcerative colitis with dermatomyositis.
  • Condition: Polymyositis /Dermatomyositis Associated ILD
  • Journal: Respiratory medicine
  • Treatment Used: Ultra-low Dose Rituximab
  • Number of Patients: 40
  • Published —
The study researched the outcomes of ultra-low dose rituximab for patients with polymyositis /dermatomyositis associated interstitial lung disease.
  • Condition: Antimelanoma Differentiation-associated Gene 5 Dermatomyositis with Interstitial Lung Disease and Cutaneous Ulcers
  • Journal: BMJ case reports
  • Treatment Used: Corticosteroids, Mycophenolate Mofetil, and Intravenous Immunoglobulin
  • Number of Patients: 1
  • Published —
The study researched the outcomes of treatment of a patient with antimelanoma differentiation-associated gene 5 complicated by interstitial lung disease and cutaneous ulcers.
  • Condition: Idiopathic Inflammatory Myopathy Concomitant with Heart Failure
  • Journal: International heart journal
  • Treatment Used: Methotrexate Combination Therapy
  • Number of Patients: 32
  • Published —
This study investigated the use of methotrexate combination therapy to treat patients with idiopathic inflammatory myopathy that is concomitant with heart failure.
  • Condition: Antimelanoma Differentiation-associated Gene 5 Antibody-positive Clinically Amyopathic Dermatomyositis
  • Journal: Medicine
  • Treatment Used: Tofacitinib
  • Number of Patients: 1
  • Published —
In this study, researchers evaluated the outcomes of using tofacitinib for the treatment of recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis.
  • Condition: Polyarticular Juvenile Idiopathic Arthritis
  • Journal: RMD open
  • Treatment Used: Adalimumab with or without Methotrexate
  • Number of Patients: 171
  • Published —
The study researched the outcomes of adalimumab with or without methotrexate for polyarticular juvenile idiopathic arthritis.
  • Condition: Juvenile Dermatomyositis
  • Journal: Arthritis research & therapy
  • Treatment Used: Infliximab and Adalimumab
  • Number of Patients: 60
  • Published —
In this study, researchers evaluated the outcomes of using infliximab and adalimumab for the treatment of juvenile dermatomyositis.
  • Condition: Pediatric Rheumatic Disorders in Tanzania
  • Journal: Pediatric rheumatology online journal
  • Treatment Used: Prednisolone and Methotrexate
  • Number of Patients: 52
  • Published —
This study determined the spectrum of rheumatic disorders among children in a Tanzanian hospital.
Showing 1-12 of 33